XHEL
NXTMH
Market cap81mUSD
Jul 09, Last price
9.80EUR
1D
-1.21%
1Q
6.52%
Jan 2017
-36.90%
IPO
-98.38%
Name
Nexstim Oyj
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nexstim Plc, a medical technology enterprise, specializes in the creation and global distribution of non-invasive brain stimulation technologies, with operations spanning Finland, Europe, North America, and other international markets. Central to its offerings is the proprietary SmartFocus technology, featuring 3D navigation, which underpins its navigated transcranial magnetic stimulation (TMS) approach utilized for both therapeutic interventions and diagnostic assessments. The company provides two distinct systems: the NBT system, a navigated brain therapy solution designed for addressing major depression and chronic neuropathic pain, and the NBS system, a navigated brain stimulation device engineered for precise pre-surgical mapping of the brain's speech and motor cortices. Nexstim predominantly sells its NBS systems to academic institutions and teaching hospitals. Established in 2000, Nexstim Plc's corporate headquarters are located in Helsinki, Finland.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||